{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,30]],"date-time":"2026-09-30T11:26:53Z","timestamp":1790767613560,"version":"4.1.0"},"reference-count":57,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2021,9,30]],"date-time":"2021-09-30T00:00:00Z","timestamp":1632960000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2021,9,30]],"date-time":"2021-09-30T00:00:00Z","timestamp":1632960000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Science Foundation of China","doi-asserted-by":"crossref","award":["51272287"],"award-info":[{"award-number":["51272287"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/501100001809","name":"National Science Foundation of China","doi-asserted-by":"crossref","award":["51272287"],"award-info":[{"award-number":["51272287"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/501100001809","name":"National Science Foundation of China","doi-asserted-by":"crossref","award":["51272287"],"award-info":[{"award-number":["51272287"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Sci Rep"],"abstract":"<jats:title>Abstract<\/jats:title><jats:p>Ischemic heart disease (IHD) and dilated cardiomyopathy (DCM) are the two most common etiologies of heart failure (HF). Both forms share common characteristics including ventricle dilation in the final stage. Immune mechanisms in HF are increasingly highlighted and have been implicated in the pathogeneses of IHD and DCM. A better understanding of adhesion molecule expression and correlated immune cell infiltration could enhance disease detection and improve therapeutic targets. This study was performed to explore the common mechanisms underlying IHD and DCM. After searching the Gene Expression Omnibus database, we selected the GSE42955, GSE76701, GSE5406, GSE133054 and GSE57338 datasets for different expressed gene (DEGs) selection and new cohort establishment. We use xcell to calculate immune infiltration degree, ssGSEA and GSEA to calculate the pathway and biological enrichment score, consensus cluster to identify the m6A modification pattern, and LASSO regression to make risk predicting model and use new combined cohort to validate the results. The screening stage revealed that vascular cell adhesion molecule 1 (VCAM1) play pivotal roles in regulating DEGs. Subsequent analyses revealed that VCAM1 was differentially expressed in the myocardium and involved in regulating immune cell infiltration. We also found that dysregulated VCAM1 expression was associated with a higher risk of HF by constructing a clinical risk-predicting model. Besides, we also find a connection among the m6A RNA modification ,expression of VCAM1 and immune regulation. Those connection can be linked by the Wnt pathway enrichment alternation. Collectively, our results suggest that VCAM-1 have the potential to be used as a biomarker or therapy target for HF and the m6A modification pattern is associated with the VCAM1 expression and immune regulation.<\/jats:p>","DOI":"10.1038\/s41598-021-98998-3","type":"journal-article","created":{"date-parts":[[2021,9,30]],"date-time":"2021-09-30T10:30:41Z","timestamp":1632997841000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":37,"title":["VCAM1 expression in the myocardium is associated with the risk of heart failure and immune cell infiltration in myocardium"],"prefix":"10.1038","volume":"11","author":[{"given":"Tongyu","family":"Wang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jiahu","family":"Tian","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuanzhe","family":"Jin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2021,9,30]]},"reference":[{"key":"98998_CR1","doi-asserted-by":"publisher","first-page":"e002594","DOI":"10.1161\/CIRCHEARTFAILURE.115.002594","volume":"9","author":"KE Bergethon","year":"2016","unstructured":"Bergethon, K. E., Ju, C., Devore, A. D., Hardy, N. C. & Hernandez, A. F. Trends in 30-day readmission rates for patients hospitalized with heart failure clinical perspective: findings from the get with the guidelines-heart failure registry. Circ. Heart Fail 9, e002594 (2016).","journal-title":"Circ. Heart Fail"},{"key":"98998_CR2","doi-asserted-by":"publisher","first-page":"1318","DOI":"10.1053\/euhj.2000.2533","volume":"22","author":"Mosterd","year":"2001","unstructured":"Mosterd. The prognosis of heart failure in the general population: The Rotterdam Study. Eur. Heart J. 22, 1318\u20131327 (2001).","journal-title":"Eur. Heart J."},{"key":"98998_CR3","doi-asserted-by":"crossref","unstructured":"Elliott & P. Cardiomyopathy: diagnosis and management of dilated cardiomyopathy. Heart 84, 106 (2000).","DOI":"10.1136\/heart.84.1.106"},{"key":"98998_CR4","doi-asserted-by":"crossref","unstructured":"Qu, X. K. et al. Prevalence and spectrum of LRRC10 mutations associated with idiopathic dilated cardiomyopathy. Mol. Med. Rep. (2015).","DOI":"10.3892\/mmr.2015.3843"},{"key":"98998_CR5","unstructured":"Schultheiss, H. P. et al. Dilated cardiomyopathy. Nat. Public Health Emerg. Collect. 5 (2019)."},{"key":"98998_CR6","doi-asserted-by":"crossref","unstructured":"Eckhouse et al. Gene targeting in ischemic heart disease and failure: translational and clinical studies. Biochem. Pharmacol. (2013).","DOI":"10.1016\/j.bcp.2012.08.018"},{"key":"98998_CR7","doi-asserted-by":"publisher","first-page":"1005","DOI":"10.1093\/nar\/gkq1184","volume":"39","author":"T Barrett","year":"2013","unstructured":"Barrett, T. et al. NCBI GEO: archive for functional genomics data sets\u2014update. Nucleic Acids Res. 39, 1005\u20131010 (2013).","journal-title":"Nucleic Acids Res."},{"key":"98998_CR8","doi-asserted-by":"publisher","first-page":"277","DOI":"10.1067\/mhj.2001.112683","volume":"141","author":"D Tousoulis","year":"2001","unstructured":"Tousoulis, D. et al. Increased plasma adhesion molecule levels in patients with heart failure who have ischemic heart disease and dilated cardiomyopathy. Am. Heart J. 141, 277\u2013280 (2001).","journal-title":"Am. Heart J."},{"key":"98998_CR9","doi-asserted-by":"publisher","first-page":"331","DOI":"10.1016\/S1388-9842(02)00021-1","volume":"4","author":"JL Alonso-Mart\u00ednez","year":"2014","unstructured":"Alonso-Mart\u00ednez, J. L., Llorente-Diez, B., Echegaray-Agara, M., Olaz-Preciado, F. & Gonz\u00e1lez-Arencibia, C. C-reactive protein as a predictor of improvement and readmission in heart failure. Eur. J. Heart Fail. 4, 331\u2013336 (2014).","journal-title":"Eur. J. Heart Fail."},{"key":"98998_CR10","doi-asserted-by":"publisher","first-page":"105","DOI":"10.1002\/jcla.21570","volume":"27","author":"A Savic-Radojevic","year":"2013","unstructured":"Savic-Radojevic, A., Radovanovic, S., Pekmezovic, T., Pljesa-Ercegovac, M. & Simic, T. The role of serum VCAM-1 and TNF-\u03b1 as predictors of mortality and morbidity in patients with chronic heart failure. J. Clin. Lab. Anal. 27, 105\u2013112 (2013).","journal-title":"J. Clin. Lab. Anal."},{"key":"98998_CR11","doi-asserted-by":"publisher","first-page":"347","DOI":"10.1016\/j.ijcard.2007.02.037","volume":"125","author":"Y Michowitz","year":"2008","unstructured":"Michowitz, Y. et al. Predictive value of high sensitivity CRP in patients with diastolic heart failure. Int. J. Cardiol. 125, 347\u2013351 (2008).","journal-title":"Int. J. Cardiol."},{"key":"98998_CR12","doi-asserted-by":"publisher","first-page":"296","DOI":"10.1093\/eurheartj\/ehr260","volume":"33","author":"D Jacoby","year":"2012","unstructured":"Jacoby, D. & McKenna, W. J. Genetics of inherited cardiomyopathy. Eur. Heart J. 33, 296 (2012).","journal-title":"Eur. Heart J."},{"key":"98998_CR13","doi-asserted-by":"publisher","first-page":"1907","DOI":"10.1089\/ars.2006.8.1907","volume":"8","author":"NG Frangogiannis","year":"2006","unstructured":"Frangogiannis, N. G. The mechanistic basis of infarct healing. Antioxid. Redox Signal. 8, 1907\u20131939. https:\/\/doi.org\/10.1089\/ars.2006.8.1907 (2006).","journal-title":"Antioxid. Redox Signal."},{"key":"98998_CR14","doi-asserted-by":"publisher","first-page":"163","DOI":"10.1016\/j.tcm.2005.06.005","volume":"15","author":"NG Frangogiannis","year":"2005","unstructured":"Frangogiannis, N. G. & Entman, M. L. Chemokines in myocardial ischemia. Trends Cardiovasc. Med. 15, 163\u2013169 (2005).","journal-title":"Trends Cardiovasc. Med."},{"key":"98998_CR15","doi-asserted-by":"publisher","first-page":"1652","DOI":"10.1161\/CIRCULATIONAHA.111.044164","volume":"125","author":"U Hofmann","year":"2012","unstructured":"Hofmann, U. et al. Activation of CD4+ T lymphocytes improves wound healing and survival after experimental myocardial infarction in MiceClinical perspective. Circulation 125, 1652 (2012).","journal-title":"Circulation"},{"key":"98998_CR16","first-page":"382","volume":"52","author":"M Kazuaki","year":"2010","unstructured":"Kazuaki, M. et al. Regulatory T lymphocytes attenuate myocardial infarction-induced ventricular remodeling in mice. Int. Heart J. 52, 382\u2013387 (2010).","journal-title":"Int. Heart J."},{"key":"98998_CR17","doi-asserted-by":"publisher","first-page":"220","DOI":"10.1186\/s13059-017-1349-1","volume":"18","author":"D Aran","year":"2017","unstructured":"Aran, D., Hu, Z. & Butte, A. J. xCell: digitally portraying the tissue cellular heterogeneity landscape. Genome Biol. 18, 220 (2017).","journal-title":"Genome Biol."},{"key":"98998_CR18","doi-asserted-by":"crossref","unstructured":"Subramanian, A. et al. Gene set enrichment analysis: a knowledge-based approach for interpreting genome-wide expression profiles (2005).","DOI":"10.1073\/pnas.0506580102"},{"key":"98998_CR19","doi-asserted-by":"publisher","first-page":"72","DOI":"10.1186\/s13578-021-00583-8","volume":"11","author":"Z Fang","year":"2021","unstructured":"Fang, Z., Hu, Y., Hu, J., Huang, Y. & Guo, C. The crucial roles of N6-methyladenosine (m6A) modification in the carcinogenesis and progression of colorectal cancer. Cell Biosci. 11, 72 (2021).","journal-title":"Cell Biosci."},{"key":"98998_CR20","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.jchf.2012.10.002","volume":"1","author":"E Braunwald","year":"2013","unstructured":"Braunwald, E. Heart failure. JACC Heart Failure 1, 1\u201320 (2013).","journal-title":"JACC Heart Failure"},{"key":"98998_CR21","doi-asserted-by":"publisher","first-page":"1105","DOI":"10.1002\/ehf2.12555","volume":"6","author":"D Tomasoni","year":"2019","unstructured":"Tomasoni, D., Adamo, M., Lombardi, C. M. & Metra, M. Highlights in heart failure. ESC Heart Failure 6, 1105\u20131127 (2019).","journal-title":"ESC Heart Failure"},{"key":"98998_CR22","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s12864-018-5213-9","volume":"19","author":"ME Sweet","year":"2018","unstructured":"Sweet, M. E., Cocciolo, A., Slavov, D., Jones, K. L. & Taylor, M. R. G. Transcriptome analysis of human heart failure reveals dysregulated cell adhesion in dilated cardiomyopathy and activated immune pathways in ischemic heart failure. BMC Genomics 19, 1\u201314 (2018).","journal-title":"BMC Genomics"},{"key":"98998_CR23","doi-asserted-by":"publisher","first-page":"92","DOI":"10.1160\/TH13-02-0088","volume":"109","author":"B Wrigley","year":"2013","unstructured":"Wrigley, B., Shantsila, E., Tapp, L. & Gregory, L. Increased expression of cell adhesion molecule receptors on monocyte subsets in ischaemic heart failure. Thromb. Haemost. 109, 92\u2013100 (2013).","journal-title":"Thromb. Haemost."},{"issue":"11","key":"98998_CR24","doi-asserted-by":"publisher","first-page":"1379","DOI":"10.1002\/ejhf.942","volume":"19","author":"Y Zhang","year":"2017","unstructured":"Zhang, Y., Bauersachs, J. & Langer, H. F. Immune mechanisms in heart failure. Eur. J. Heart Failure 19(11), 1379\u20131389 (2017).","journal-title":"Eur. J. Heart Failure"},{"key":"98998_CR25","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1146\/annurev-physiol-021119-034412","volume":"82","author":"A Rhee","year":"2020","unstructured":"Rhee, A. & Lavine, K. New approaches to target inflammation in heart failure: harnessing insights from studies of immune cell diversity. Annu. Rev. Physiol. 82, 1\u201320. https:\/\/doi.org\/10.1146\/annurev-physiol-021119-034412 (2020).","journal-title":"Annu. Rev. Physiol."},{"issue":"12","key":"98998_CR26","doi-asserted-by":"publisher","first-page":"1484","DOI":"10.1038\/nm960","volume":"9","author":"U Eriksson","year":"2003","unstructured":"Eriksson, U. et al. Dendritic cell\u2013induced autoimmune heart failure requires cooperation between adaptive and innate immunity. Nat. Med. 9(12), 1484\u20131490 (2003).","journal-title":"Nat. Med."},{"key":"98998_CR27","doi-asserted-by":"publisher","first-page":"2164017","DOI":"10.1155\/2019\/2164017","volume":"2019","author":"D Strassheim","year":"2019","unstructured":"Strassheim, D., Dempsey, E., Gerasimovskaya, E., Stenmark, K. & Karoor, V. Role of inflammatory cell subtypes in heart failure. J. Immunol. Res. 2019, 2164017. https:\/\/doi.org\/10.1155\/2019\/2164017 (2019).","journal-title":"J. Immunol. Res."},{"key":"98998_CR28","doi-asserted-by":"publisher","first-page":"20","DOI":"10.1016\/j.clim.2018.03.015","volume":"192","author":"MA Moro-Garc\u00eda","year":"2018","unstructured":"Moro-Garc\u00eda, M. A., L\u00f3pez-Iglesias, F., Marcos-Fern\u00e1ndez, R., Bueno-Garc\u00eda, E. & Alonso-Arias, R. More intensive CMV-infection in chronic heart failure patients contributes to higher T-lymphocyte differentiation degree. Clin. Immunol. 192, 20\u201329 (2018).","journal-title":"Clin. Immunol."},{"key":"98998_CR29","doi-asserted-by":"publisher","first-page":"e125527","DOI":"10.1172\/jci.insight.125527","volume":"4","author":"N Ngwenyama","year":"2019","unstructured":"Ngwenyama, N. et al. CXCR3 regulates CD4+ T cell cardiotropism in pressure overload\u2013induced cardiac dysfunction. JCI Insight 4, e125527 (2019).","journal-title":"JCI Insight"},{"key":"98998_CR30","doi-asserted-by":"publisher","first-page":"2665","DOI":"10.3389\/fimmu.2018.02665","volume":"9","author":"C Gr\u00f6schel","year":"2018","unstructured":"Gr\u00f6schel, C., Sasse, A., Monecke, S., R\u00f6hrborn, C. & Dressel, R. CD8 +-T cells with specificity for a model antigen in cardiomyocytes can become activated after transverse aortic constriction but do not accelerate progression to heart failure. Front. Immunol. 9, 2665 (2018).","journal-title":"Front. Immunol."},{"key":"98998_CR31","doi-asserted-by":"publisher","first-page":"2111","DOI":"10.1161\/CIRCULATIONAHA.113.007101","volume":"129","author":"F Laroumanie","year":"2014","unstructured":"Laroumanie, F., Douin-Echinard, V., Pozzo, J., Lairez, O. & Pizzinat, N. CD4(+) T cells promote the transition from hypertrophy to heart failure during chronic pressure overload. Circulation 129, 2111 (2014).","journal-title":"Circulation"},{"key":"98998_CR32","doi-asserted-by":"publisher","first-page":"1021","DOI":"10.1161\/CIRCRESAHA.115.306565","volume":"118","author":"JG Travers","year":"2016","unstructured":"Travers, J. G., Kamal, F. A., Robbins, J., Yutzey, K. E. & Blaxall, B. C. Cardiac fibrosis: the fibroblast awakens. Circ. Res. 118, 1021\u20131040 (2016).","journal-title":"Circ. Res."},{"key":"98998_CR33","doi-asserted-by":"publisher","first-page":"3311","DOI":"10.1084\/jem.20161791","volume":"214","author":"T Nevers","year":"2017","unstructured":"Nevers, T. et al. Th1 effector T cells selectively orchestrate cardiac fibrosis in nonischemic heart failure. J. Exp. Med. 214, 3311 (2017).","journal-title":"J. Exp. Med."},{"key":"98998_CR34","doi-asserted-by":"publisher","first-page":"711","DOI":"10.1038\/s41591-018-0064-0","volume":"24","author":"N Matthias","year":"2018","unstructured":"Matthias, N. Myeloid cell contributions to cardiovascular health and disease. Nat. Med. 24, 711\u2013720 (2018).","journal-title":"Nat. Med."},{"key":"98998_CR35","doi-asserted-by":"crossref","first-page":"e007849","DOI":"10.1161\/JAHA.117.007849","volume":"7","author":"F Shahid","year":"2018","unstructured":"Shahid, F., Lip, G. Y. H. & Shantsila, E. Role of monocytes in heart failure and atrial fibrillation. J. Am. Heart Assoc. Cardiovasc. Cerebrovasc. Dis. 7, e007849 (2018).","journal-title":"J. Am. Heart Assoc. Cardiovasc. Cerebrovasc. Dis."},{"key":"98998_CR36","doi-asserted-by":"publisher","first-page":"853","DOI":"10.1161\/CIRCRESAHA.116.309001","volume":"119","author":"HB Sager","year":"2016","unstructured":"Sager, H. B., Hulsmans, M., Lavine, K. J., Moreira, M. B. B. & Nahrendorf, M. Proliferation and recruitment contribute to myocardial macrophage expansion in chronic heart failure. Circ. Res. 119, 853 (2016).","journal-title":"Circ. Res."},{"key":"98998_CR37","doi-asserted-by":"publisher","first-page":"e85851","DOI":"10.1172\/jci.insight.85851","volume":"1","author":"JM Myers","year":"2016","unstructured":"Myers, J. M., Cooper, L. T., Kem, D. C., Stavrakis, S. & Cunningham, M. W. Cardiac myosin-Th17 responses promote heart failure in human myocarditis. Jci Insight 1, e85851 (2016).","journal-title":"Jci Insight"},{"key":"98998_CR38","doi-asserted-by":"publisher","first-page":"568","DOI":"10.1038\/ni.2031","volume":"12","author":"M El-Behi","year":"2011","unstructured":"El-Behi, M. et al. The encephalitogenicity of T(H)17 cells is dependent on IL-1- and IL-23-induced production of the cytokine GM-CSF. Nat. Immunol. 12, 568\u2013575. https:\/\/doi.org\/10.1038\/ni.2031 (2011).","journal-title":"Nat. Immunol."},{"key":"98998_CR39","doi-asserted-by":"publisher","first-page":"e13537","DOI":"10.1111\/apha.13537","volume":"230","author":"M Lu","year":"2020","unstructured":"Lu, M. et al. Th17\/Treg imbalance modulates rat myocardial fibrosis and heart failure by regulating LOX expression. Acta Physiol (Oxf.) 230, e13537. https:\/\/doi.org\/10.1111\/apha.13537 (2020).","journal-title":"Acta Physiol (Oxf.)"},{"key":"98998_CR40","doi-asserted-by":"publisher","first-page":"258","DOI":"10.1161\/CIRCULATIONAHA.105.564294","volume":"113","author":"RR Marty","year":"2006","unstructured":"Marty, R. R. MyD88 signaling controls autoimmune myocarditis induction. Circulation 113, 258 (2006).","journal-title":"Circulation"},{"key":"98998_CR41","doi-asserted-by":"publisher","first-page":"835","DOI":"10.3389\/fimmu.2018.00835","volume":"9","author":"H Katharina","year":"2018","unstructured":"Katharina, H., Ann-Katrin, C. & Armin, M. R. Targeting B cells and plasma cells in autoimmune diseases. Front. Immunol. 9, 835 (2018).","journal-title":"Front. Immunol."},{"key":"98998_CR42","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1097\/MOT.0000000000000708","volume":"24","author":"RG Gill","year":"2019","unstructured":"Gill, R. G. & Lin, C. M. Linking innate immunity and chronic antibody-mediated allograft rejection. Curr. Opin. Organ Transplant. 24, 1 (2019).","journal-title":"Curr. Opin. Organ Transplant."},{"key":"98998_CR43","first-page":"1679","volume":"48","author":"Z Prohaszka","year":"2011","unstructured":"Prohaszka, Z. et al. Association of Ficolin-3 with severity and outcome of chronic heart failure. PLoS ONE 48, 1679\u20131680 (2011).","journal-title":"PLoS ONE"},{"key":"98998_CR44","doi-asserted-by":"publisher","first-page":"479","DOI":"10.1358\/dot.2012.48.7.1811719","volume":"48","author":"K Broch","year":"2012","unstructured":"Broch, K., Ueland, T., Yndestad, A., Aukrust, P. & Gullestad, L. Heart failure biomarkers: focus on interleukin-1 receptor-like 1-based blood tests. Drugs of Today 48, 479 (2012).","journal-title":"Drugs of Today"},{"key":"98998_CR45","doi-asserted-by":"publisher","first-page":"e0210273","DOI":"10.1371\/journal.pone.0210273","volume":"14","author":"L Camacho","year":"2019","unstructured":"Camacho, L. et al. Identification of whole blood mRNA and microRNA biomarkers of tissue damage and immune function resulting from amphetamine exposure or heat stroke in adult male rats. PLoS ONE 14, e0210273 (2019).","journal-title":"PLoS ONE"},{"key":"98998_CR46","doi-asserted-by":"publisher","first-page":"118","DOI":"10.1016\/j.lfs.2018.01.021","volume":"196","author":"JL Williams","year":"2018","unstructured":"Williams, J. L. et al. Defining the molecular signatures of human right heart failure. Life Sci. 196, 118 (2018).","journal-title":"Life Sci."},{"key":"98998_CR47","doi-asserted-by":"publisher","first-page":"117347","DOI":"10.1016\/j.lfs.2020.117347","volume":"245","author":"Y Guo","year":"2020","unstructured":"Guo, Y., Jia, P., Chen, Y., Yu, H. & Jia, D. PHLDA1 is a new therapeutic target of oxidative stress and ischemia reperfusion-induced myocardial injury. Life Sci. 245, 117347 (2020).","journal-title":"Life Sci."},{"key":"98998_CR48","first-page":"1437","volume":"11","author":"D Li","year":"2020","unstructured":"Li, D., Lin, H. & Li, L. Multiple feature selection strategies identified novel cardiac gene expression signature for heart failure. Front. Physiol. 11, 1437 (2020).","journal-title":"Front. Physiol."},{"issue":"5","key":"98998_CR49","doi-asserted-by":"publisher","first-page":"501","DOI":"10.1038\/s41590-020-0650-4","volume":"21","author":"Z Shulman","year":"2020","unstructured":"Shulman, Z. & Stern-Ginossar, N. methyladenosine as a novel regulator of the immune system. Nat. Immunol. 21(5), 501\u2013512 (2020).","journal-title":"Nat. Immunol."},{"key":"98998_CR50","doi-asserted-by":"publisher","first-page":"207","DOI":"10.3390\/cells10020207","volume":"10","author":"EP Daskalopoulos","year":"2021","unstructured":"Daskalopoulos, E. P. & Blankesteijn, W. M. Effect of interventions in WNT signaling on healing of cardiac injury: a systematic review. Cells 10, 207 (2021).","journal-title":"Cells"},{"key":"98998_CR51","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1007\/s00395-018-0705-y","volume":"113","author":"S Meyer","year":"2018","unstructured":"Meyer, S. & Leuschner, F. The role of Wnt signaling in the healing myocardium: a focus on cell specificity. Basic Res. Cardiol. 113, 1\u201312 (2018).","journal-title":"Basic Res. Cardiol."},{"key":"98998_CR52","doi-asserted-by":"crossref","first-page":"e019390","DOI":"10.1161\/JAHA.120.019390","volume":"9","author":"RB Patel","year":"2020","unstructured":"Patel, R. B., Colangelo, L. A., Bielinski, S. J., Larson, N. B. & LloydOnes, D. Circulating vascular cell adhesion moleculeand incident heart failure: the multiethnic study of atherosclerosis (MESA). J. Am. Heart Assoc. 9, e019390 (2020).","journal-title":"J. Am. Heart Assoc."},{"key":"98998_CR53","doi-asserted-by":"publisher","first-page":"105","DOI":"10.1002\/jcla.21570","volume":"27","author":"A Savic-Radojevic","year":"2013","unstructured":"Savic-Radojevic, A. et al. The role of serum VCAM-1 and TNF-\u03b1 as predictors of mortality and morbidity in patients with chronic heart failure. J. Clin. Lab. Anal. 27, 105\u2013112. https:\/\/doi.org\/10.1002\/jcla.21570 (2013).","journal-title":"J. Clin. Lab. Anal."},{"key":"98998_CR54","doi-asserted-by":"publisher","first-page":"166170","DOI":"10.1016\/j.bbadis.2021.166170","volume":"1867","author":"M Troncoso","year":"2021","unstructured":"Troncoso, M. et al. VCAM-1 as a predictor biomarker in cardiovascular disease. Biochim. Biophysica Acta Mol. Basis Dis. 1867, 166170. https:\/\/doi.org\/10.1016\/j.bbadis.2021.166170 (2021).","journal-title":"Biochim. Biophysica Acta Mol. Basis Dis."},{"key":"98998_CR55","doi-asserted-by":"publisher","first-page":"1258","DOI":"10.1093\/eurheartj\/ehm011","volume":"28","author":"H Theiss","year":"2007","unstructured":"Theiss, H. et al. Circulation of CD34+ progenitor cell populations in patients with idiopathic dilated and ischaemic cardiomyopathy (DCM and ICM). Eur. Heart J. 28, 1258\u20131264. https:\/\/doi.org\/10.1093\/eurheartj\/ehm011 (2007).","journal-title":"Eur. Heart J."},{"key":"98998_CR56","doi-asserted-by":"publisher","first-page":"1077","DOI":"10.1056\/nejm200004133421502","volume":"342","author":"G Felker","year":"2000","unstructured":"Felker, G. et al. Underlying causes and long-term survival in patients with initially unexplained cardiomyopathy. N. Engl. J. Med. 342, 1077\u20131084. https:\/\/doi.org\/10.1056\/nejm200004133421502 (2000).","journal-title":"N. Engl. J. Med."},{"key":"98998_CR57","doi-asserted-by":"publisher","first-page":"29","DOI":"10.1093\/nar\/27.1.29","volume":"27","author":"H Ogata","year":"1999","unstructured":"Ogata, H., Goto, S., Sato, K., Fujibuchi, W. & Kanehisa, M. KEGG: kyoto encyclopedia of genes and genomes. Nucleic Acids Res. 27, 29\u201334 (1999).","journal-title":"Nucleic Acids Res."}],"container-title":["Scientific Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41598-021-98998-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-021-98998-3","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-021-98998-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,12,3]],"date-time":"2022-12-03T16:05:42Z","timestamp":1670083542000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41598-021-98998-3"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,9,30]]},"references-count":57,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2021,12]]}},"alternative-id":["98998"],"URL":"https:\/\/doi.org\/10.1038\/s41598-021-98998-3","relation":{},"ISSN":["2045-2322"],"issn-type":[{"value":"2045-2322","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,9,30]]},"assertion":[{"value":"25 June 2021","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"17 September 2021","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"30 September 2021","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"19488"}}